BB BIOTECH overview

BB Biotech is managed by Bellevue Asset Management, a Swiss-based asset manager specialising in healthcare investments....

EQS-Ad-hoc: BB BIOTECH AG / Key word(s): Interim Report BB Biotech AG publishes its interim report 25-Oct-2024 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR October 25, 2024 BB Biotech AG publishes its interim report BB Biotech AG (ISIN CH0038389992) today published...

EQS-News: BB BIOTECH AG / Key word(s): Interim Report BB Biotech: Strategic reallocation of portfolio assets progressing 25.10.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as at October 25, 2024 Portfolio of BB Biotech AG as at September 30, 2024 BB Biotech: Strategic reallocation of portfolio assets progressing In the third quarter of 2024, stock markets remained volatile. The recent rate cut by the US central bank has improved the...

Edison Investment Research Limited Edison issues report on BB Biotech (BION) 23-Oct-2024 / 09:12 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 23 October 2024 Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION). BB Biotech (BION) invests in innovative, rapidly expanding biotech companies. BION’s portfolio company Wave Life Sciences (Wave) recently announced a significant milestone in the field of genetic medicine: the...

In our third Deep dive into artificial intelligence interview, we are joined by Rosanne Kincaid-Smith, the chief operating officer of ......

EQS-News: BB BIOTECH AG / Key word(s): Interim Report Substantial pipeline progress at several portfolio companies offsets rate-related market volatility 26.07.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as at July 26, 2024 Portfolio of BB Biotech AG as at June 30, 2024 Substantial pipeline progress at several portfolio companies offsets rate-related market volatility Global equity indices climbed to new record highs during the...

EQS-Ad-hoc: BB BIOTECH AG / Key word(s): Interim Report/Personnel BB Biotech AG publishes its interim report and announces a new head of its investment management team 26-Jul-2024 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR July 26, 2024 BB Biotech AG publishes its...

Edison Investment Research Limited Edison issues report on BB Biotech (BION) 26-Jun-2024 / 13:08 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 26 Juni 2024 Edison issues report on BB Biotech (BION) Click here to view the full report. All reports published by Edison are available to download free of charge from its website www.edisongroup.com Edison is authorised and regulated by the Financial Conduct Authority . Edison is not an adviser or...